Biotech giant CSL have announced their new headquarters and state-of-the-art laboratories will be housed within the $1 billion Elizabeth North precinct in Parkville.
The building will contain seven floors of office space and nine floors of laboratories and research and clinical phase production suites.
The precinct, which is being developed by PDG, was originally proposed as a 1000-dwelling residential project when purchased from Toyota in 2017. The switch to commercial may be a result of Melbourne’s recent apartment downturn.
According to Australian Financial Review, PDG Managing Director Vince Giuliano said the original plans for the block were tempting, however “when you look at the infrastructure which is being created with the metro tunnel, the existing biomedical precinct, we decided to take a longer term view.”
Related News: PDG’s Elizabeth North Project Finally Headed to Tender
CSL’s decision to move its headquarters from Poplar Road, next to Royal Park, was made strategically, to place the company closer to key stakeholders and amongst Melbourne’s thriving biomedical research community.
The site will comprise three towers, with CSL committed to the 35,000 square metre centre building.
Toyota and Trinity College have committed to the outer buildings.
The precinct will include external laneways to bridge the buildings with Parkville’s existing educational and medical hub, and the CBD.
Outdoor areas will be developed into public spaces optimised for networking between professionals, researchers, students and visitors.
Construction of phases one and two will employ almost 1,350 people, with the whole project slated for completion in 2024.
When your career requires change or development, Conecta provides today’s most relevant jobs and news. Create your free profile today.
Download our Free 2019 Salary Guide
Over 15,000 readers and subscribers stay connected with the latest news and jobs in the Melbourne construction & engineering industry.